作为广泛作用的抗病毒药物的Farnesoid X受体激活剂:来自肝炎病毒及其他病毒的证据?
Barnault Romain1, Vicente-Navarro Inés1, Lotteau Vincent1
1CIRI, Centre International de Recherche en Infectiologie, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007, Lyon, France.
Antiviral research
|July 3, 2025
概括
法尔内索伊德X受体α (FXRα) 激动剂通过影响病毒复制的多个步骤,显示出广泛的抗病毒潜力. 它们已确立的安全概况表明,它们可以用于病毒感染.
科学领域:
- 分子生物学分子生物学
- 病毒学 病毒学
- 代谢调节 代谢调节 代谢调节
背景情况:
- 病毒依赖宿主细胞代谢来进行复制.
- 法尔内索伊德X受体α (FXRα) 是一个调节新陈代谢和免疫力的核受体.
- FXRα配体用于代谢综合征治疗.
研究的目的:
- 审查有关FXRα激动因子在病毒感染中的作用的文献.
- 探索FXRα作为广泛的抗病毒剂的潜力.
主要方法:
- 对研究FXRα和病毒病原体的综合文献综述.
- 对FXRα在调节病毒生命周期中的报告机制的分析.
主要成果:
- FXRα激动作用会影响各种病毒的复制,包括肝发性病毒和肠道病毒.
- FXRα影响病毒复制的多个阶段,如入口,转录和颗粒释放.
- FXRα似乎不通过单一的抗病毒机制起作用.
结论:
- FXRα在调节病毒生命周期方面发挥着重要作用.
- FXRα激动剂显示出作为广泛的抗病毒药物的潜力.
- 现有的FXRα激动剂,具有既定的安全性,可以重新用于抗病毒疗法.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.7K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.7K
Subviral Agents
124
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
124
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K
Retroviruses
12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
Antiasthma Drugs: Muscarinic Receptor Antagonists
468
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
468
Drug-Receptor Interaction: Antagonist
3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K


